Angiogenesis inhibitory drug combination obtained according to a specific algorithm, preferably a FSC, in which an initial combination of drugs is iteratively adjusted. The drug combination according to the invention may advantageously comprise a RAPTA-C compound. In a more specific case the combination comprises RAPTA-C and eriotinib.
Giovanni De Micheli, Mathias Soeken, Bruno Schmitt Antunes
Alcherio Martinoli, Cyrill Silvan Baumann, Jonas Perolini, Emna Tourki
, , , , ,